|
*Bravecto Topical Solution for Cats kills fleas, prevents flea infestations, and kills ticks (black-legged tick) for 12 weeks. Bravecto also kills American dog ticks for 8 weeks.
|
IMPORTANT SAFETY INFORMATION: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto has not been shown to be effective for 12-weeks' duration in kittens less than 6 months of age. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.
|
VIEW PRESCRIBING INFORMATION
|
References: 1. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.
|
To opt-out of further Merck Animal Health communications click here. |
Copyright © 2017 Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc. All rights reserved.
|
|
|
|
|